Peptide-based inhibitors of PTP1b / NCK1 interaction and methods of making and using same
TW202626693APending Publication Date: 2026-07-01RADELLA PHARM LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114132701
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-06-23
- Filing Date
- 2025-08-27
- Publication Date
- 2026-07-01
Abstract
The disclosure relates generally to synthetic peptides which bind NCK1. The invention further relates to methods of using the peptides for inhibiting an interaction between NCK1 and PTP1B, and for treating a disease or disorder associated with insulin resistance, including type 2 diabetes and obesity.
Need to check novelty before this filing date? Find Prior Art